Xtandi 40 MG tablet 120S
Ended Awarded
- Contract number
- SPE2DB25FYBHD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,170
Award facts
- Contract value 100% obligated
- $4,169.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc. for 120 tablets of Xtandi 40 mg, a prescription oncology medication. This firm fixed-price delivery order, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, serves as the prime contractor for this award. The company will perform the delivery from its Park Ridge location and will supply the medication to support Department of Defense healthcare requirements.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026. The IDC, awarded under the SPE2DB program, enables the agency to procure a comprehensive range of pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables to support military health facilities nationwide. As a consistently awarded supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its woman-owned small business status to compete effectively in defense procurement while providing critical pharmaceutical distribution services directly to Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FYBHD?
SPE2DB25FYBHD was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FYBHD worth?
The government has obligated $4,170 on SPE2DB25FYBHD.
Is contract SPE2DB25FYBHD an order under another contract?
Yes. SPE2DB25FYBHD is a delivery order under SPE2DB24D9313, an indefinite delivery contract.
Was contract SPE2DB25FYBHD competed?
The extent of competition for SPE2DB25FYBHD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award